Postadaptational resistance to benzalkonium chloride and subsequent physicochemical modifications of Listeria monocytogenes.
Many studies have demonstrated that bacteria, including Listeria monocytogenes, are capable of adapting to disinfectants used in industrial settings after prolonged exposure to sublethal concentrations. However, the consequent alterations of the cell surface due to sanitizer adaptation of this pathogen are not fully understood. Two resistant and four sensitive L. monocytogenes strains from different sources were progressively subcultured with increasing sublethal concentrations of a surfactant, benzalkonium chloride (BC). To evaluate the effects of acquired tolerance to BC, parent and adapted strains were compared by using several morphological and physiological tests. Sensitive strains showed at least a fivefold increase in the MIC, while the MIC doubled for resistant strains after the adaptation period. The hydrophobicities of cells of parent and adapted strains were similar. Serological testing indicated that antigen types 1 and 4 were both present on the cell surface of adapted cells. The data suggest that efflux pumps are the major mechanism of adaptation in sensitive strains and are less important in originally resistant isolates. A different, unknown mechanism was responsible for the original tolerance of resistant isolates. In an originally resistant strain, there was a slight shift in the fatty acid profile after adaptation, whereas sensitive strains had similar profiles. Electron micrographs revealed morphological differences after adaptation. The changes in cell surface antigens, efflux pump utilization, and fatty acid profiles suggest that different mechanisms are used by resistant and sensitive strains for adaptation to BC.
To
Monica S
MS
Department of Food Science, University of Guelph, Guelph, Ontario, Canada N1G 2W1.
Favrin
Stacy
S
Romanova
Nadya
N
Griffiths
Mansel W
MW
D000220:Adaptation, Biological; D000891:Anti-Infective Agents, Local / Q000494:pharmacology*; D001548:Benzalkonium Compounds / Q000494:pharmacology*; D001692:Biological Transport; D024881:Drug Resistance, Bacterial / Q000502:physiology; D005227:Fatty Acids / Q000378:metabolism; D008089:Listeria monocytogenes / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D008565:Membrane Proteins / Q000378:metabolism; D026901:Membrane Transport Proteins / Q000378:metabolism
D000891:Anti-Infective Agents, Local; D001548:Benzalkonium Compounds; D005227:Fatty Acids; D008565:Membrane Proteins; D026901:Membrane Transport Proteins